Does Rallies track congressional trades in WST?

Yes. Rallies tracks politician and congressional stock disclosures for WST, including reported purchases, sales, dates, owners, and trade amounts when available.

Is WST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WST. It does not provide personalized investment advice.

WST (West Pharmaceutical Services, Inc.) Stock Analysis - Politician Trades

West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of May 20, 2026, WST trades at $308.45 with a market cap of $21.51B and a P/E ratio of 40.45. WST moved +0.46% today. Year to date, WST is +9.49%; over the trailing twelve months it is +41.81%. Its 52-week range spans $187.43 to $352.33. Analyst consensus is buy with an average price target of $347.50. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded WST stock?

Recent politician trading activity in WST includes disclosures from Jared Moskowitz, Jared Moskowitz, Ro Khanna, Jared Moskowitz, and Jared Moskowitz. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

WST Key Metrics

Key financial metrics for WST
Metric	Value
Price	$308.45
Market Cap	$21.51B
P/E Ratio	40.45
EPS	$7.52
Dividend Yield	0.22%
52-Week High	$352.33
52-Week Low	$187.43
Volume	403.36K
Avg Volume	0
Revenue (TTM)	$3.22B
Net Income	$542.70M
Gross Margin	36.28%

Congressional Trades in WST

Jared Moskowitz sale WST on Feb 13, 2025 (amount: $15.00K).
Jared Moskowitz sale WST on Nov 8, 2024 (amount: $15.00K).
Ro Khanna sale WST on Sep 9, 2024 (amount: $15.00K).
Jared Moskowitz purchase WST on Dec 28, 2023 (amount: $15.00K).
Jared Moskowitz purchase WST on Jul 14, 2023 (amount: $15.00K).

Latest WST News

West Pharmaceutical (WST) climbs as raised 2026 guidance sustains post-earnings bid — May 5, 2026
West Pharmaceutical slips as traders take profits after Q1 beat, raised 2026 outlook — Apr 28, 2026
West Pharmaceutical rallies after Q1 2026 earnings beat and higher full-year outlook — Apr 24, 2026
West Pharmaceutical Hikes 2026 Guidance After 21% Q1 Sales Gain, $1B Buyback — Apr 23, 2026
West Pharmaceutical Services Raises 2026 Sales Guidance After 21% Q1 Revenue Surge — Apr 23, 2026

Recent WST Insider Trades

Favorite Annette F sold 2.82K (~$859.75K) on Apr 27, 2026.
Winters Chad sold 896 (~$269.40K) on Apr 27, 2026.

WST Analyst Consensus

7 analysts cover WST: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $347.50.

Common questions about WST

Which politicians traded WST stock?: Recent politician trading activity in WST includes disclosures from Jared Moskowitz, Jared Moskowitz, Ro Khanna, Jared Moskowitz, and Jared Moskowitz. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in WST?: Yes. Rallies tracks politician and congressional stock disclosures for WST, including reported purchases, sales, dates, owners, and trade amounts when available.
Is WST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WST. It does not provide personalized investment advice.